about
A new look at cerebrospinal fluid circulationNon-Viral Nucleic Acid Delivery Strategies to the Central Nervous SystemNew Insights on Different Response of MDMA-Elicited Serotonin Syndrome to Systemic and Intracranial Administrations in the Rat BrainMicrobubbles and ultrasound increase intraventricular polyplex gene transfer to the brain.CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis modelA Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage.Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment.Influence of pigment epithelium-derived factor on outcome after striatal cerebral ischemia in the mouse.Therapeutic concentrations of glucagon-like peptide-1 in cerebrospinal fluid following cell-based delivery into the cerebral ventricles of catsBlockade of ENaCs by amiloride induces c-Fos activation of the area postrema.Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI.Practical steps for applying a new dynamic model to near-infrared spectroscopy measurements of hemodynamic oscillations and transient changes: implications for cerebrovascular and functional brain studiesThe Class I-Specific HDAC Inhibitor MS-275 Decreases Motivation to Consume Alcohol and Relapse in Heavy Drinking Rats.Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier.Cerebral autoregulation in the microvasculature measured with near-infrared spectroscopyHistology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.Retinal Electrophysiology Is a Viable Preclinical Biomarker for Drug Penetrance into the Central Nervous System.Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling.Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats.The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.Can insulin signaling pathways be targeted to transport Aβ out of the brain?Mahogunin Ring Finger-1 (MGRN1), a Multifaceted Ubiquitin Ligase: Recent Unraveling of Neurobiological Mechanisms.Vascular Dynamics Aid a Coupled Neurovascular Network Learn Sparse Independent Features: A Computational ModelStrategies to enhance the distribution of nanotherapeutics in the brain.Quantitative Gd-DOTA uptake from cerebrospinal fluid into rat brain using 3D VFA-SPGR at 9.4T.Histamine elimination from the cerebrospinal fluid across the blood-cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT/SLC29A4).Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury.A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site ConcentrationsTransporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells.Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue.Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy.Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury.Successful large-volume cerebrospinal fluid aspiration for an accidental overdose of intrathecal cytarabine.Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Chronic inhibition of brain glycolysis initiates epileptogenesis.
P2860
Q21195862-0B551D97-4F65-406D-8F76-20D88038DC78Q28068242-C49EE781-81A2-4C60-969C-302AD41655D3Q28552135-F303CF59-9FA4-4D2A-883C-6BD60822B6F4Q30354561-303D7E15-BE31-4B42-8A19-566CC96E064BQ30514065-9DAE2CD3-2010-498E-8182-B08114372583Q33591700-02EC138C-AA96-4255-94CC-BD83FC735246Q34550143-22BB7461-38F7-4D54-9835-37F21036EFC6Q34608390-8EF8B60C-47C5-4F33-A1A8-70F42CAAC149Q34627923-3C947092-26B2-4737-B9D6-97CA91FA40C3Q35044628-CB5E490B-112D-47A5-9C62-05C2230936BBQ35137432-AD9395DB-D921-499B-AA67-07EB9868ADEFQ35327883-D57C8B6B-CF0A-4B4E-97E6-30657DBAFA02Q35629106-73227EB9-109F-4ADE-8D64-E660406C123FQ36077200-CA0E9022-3A52-4E63-9099-28C0C33944C8Q36186589-102AA426-9710-4030-91EE-1CFEEBFF40C5Q36267239-47DE4553-F545-4E4D-9599-A831E8405E88Q36316226-1EB11E5C-FE33-4689-91C5-1104C15D32AFQ36745664-62A12320-A897-42CA-B952-04B6180325E1Q36889744-C87AE8B9-9084-4305-895C-DE075F8F89E0Q37365658-86EBBB0D-5C0D-4BF3-ABB2-E37B008039EAQ37998107-2AE56002-BFD7-4793-B2F8-31159DBABB15Q38010342-62679540-D486-491C-ADA6-F347DA76358FQ38236698-837279B8-089D-41EC-8960-063F6C4FB4F7Q38368300-D0629901-F826-434E-A24E-F9F9D8E68A2EQ38542045-AD02C85F-F92D-4309-8FBE-4E8333E4612FQ38563041-E769F11A-90C6-4F4C-BF77-91C052D9DFD1Q38636899-A38AB77D-C6FA-43CC-BABA-9164FB4D6DCEQ38663895-628837E6-B120-4D64-AAF9-4B04DDE7CB0FQ38669561-59FEBE96-8663-44DA-8A38-EA37B9AAD354Q38738684-1467834C-3C83-4999-B50D-A89DE7B6C390Q38867048-42F45C69-E1DB-4B28-9984-9FD0DFEE0E64Q38876101-9FD2C3C0-8495-43A1-895F-74E784C7B5E6Q39172795-4A3BBDBE-34C2-4BF6-B02E-9DB23F3FACB0Q40486362-74A33A86-FEDF-4131-860E-3764C2921CADQ41029307-9BF17194-6673-4E02-88BE-A86B2613D3C7Q42065629-C057ADE1-DDFC-4152-BC97-15A08360272CQ42266180-1F44A0F7-39D2-4604-9296-450D9EAA24FEQ44916384-F0790AEC-6F9F-483F-B7BB-5B849BDD557AQ47743028-20C8AA10-EE4A-42F4-BE4A-EBCD53636A76Q48048374-A97C5C2F-588A-4E2A-8BA3-D62FA549939A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Drug transport in brain via the cerebrospinal fluid
@ast
Drug transport in brain via the cerebrospinal fluid
@en
Drug transport in brain via the cerebrospinal fluid
@en-gb
Drug transport in brain via the cerebrospinal fluid
@nl
type
label
Drug transport in brain via the cerebrospinal fluid
@ast
Drug transport in brain via the cerebrospinal fluid
@en
Drug transport in brain via the cerebrospinal fluid
@en-gb
Drug transport in brain via the cerebrospinal fluid
@nl
prefLabel
Drug transport in brain via the cerebrospinal fluid
@ast
Drug transport in brain via the cerebrospinal fluid
@en
Drug transport in brain via the cerebrospinal fluid
@en-gb
Drug transport in brain via the cerebrospinal fluid
@nl
P2860
P3181
P356
P1476
Drug transport in brain via the cerebrospinal fluid
@en
P2860
P2888
P3181
P356
10.1186/2045-8118-8-7
P407
P577
2011-01-01T00:00:00Z
P5875
P6179
1026228590